Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP588086.RAEr7fr9x5K46YSEv1CwcW0xJCbWuxZUJED1zouwT2_io130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP588086.RAEr7fr9x5K46YSEv1CwcW0xJCbWuxZUJED1zouwT2_io130_assertion type Assertion NP588086.RAEr7fr9x5K46YSEv1CwcW0xJCbWuxZUJED1zouwT2_io130_head.
- NP588086.RAEr7fr9x5K46YSEv1CwcW0xJCbWuxZUJED1zouwT2_io130_assertion wasGeneratedBy ECO_0000203 NP588086.RAEr7fr9x5K46YSEv1CwcW0xJCbWuxZUJED1zouwT2_io130_provenance.
- NP588086.RAEr7fr9x5K46YSEv1CwcW0xJCbWuxZUJED1zouwT2_io130_assertion wasDerivedFrom befree-20140225 NP588086.RAEr7fr9x5K46YSEv1CwcW0xJCbWuxZUJED1zouwT2_io130_provenance.
- NP588086.RAEr7fr9x5K46YSEv1CwcW0xJCbWuxZUJED1zouwT2_io130_assertion SIO_000772 16793127 NP588086.RAEr7fr9x5K46YSEv1CwcW0xJCbWuxZUJED1zouwT2_io130_provenance.
- NP588086.RAEr7fr9x5K46YSEv1CwcW0xJCbWuxZUJED1zouwT2_io130_assertion evidence source_evidence_literature NP588086.RAEr7fr9x5K46YSEv1CwcW0xJCbWuxZUJED1zouwT2_io130_provenance.
- NP588086.RAEr7fr9x5K46YSEv1CwcW0xJCbWuxZUJED1zouwT2_io130_assertion description "[Low-grade EC that developed in borderline tumors had PTEN and/or K-RAS mutation (4/5, 80%), while high-grade EC had TP53 mutations only.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP588086.RAEr7fr9x5K46YSEv1CwcW0xJCbWuxZUJED1zouwT2_io130_provenance.